Complication rate after termination of pregnancy for fetal defects.
fetal defect
first-trimester screening
induction
termination of pregnancy
Journal
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
revised:
28
11
2022
received:
25
08
2022
accepted:
21
12
2022
medline:
3
7
2023
pubmed:
8
1
2023
entrez:
7
1
2023
Statut:
ppublish
Résumé
To assess the risk of complications in women undergoing termination of pregnancy (TOP) for fetal defects and to examine the impact of gestational age on the complication rate. This was a retrospective study of women with a singleton pregnancy undergoing TOP at the University Hospital of Tübingen, Germany, between 2018 and 2021. TOP was performed by experienced operators according to the national protocol; dilatation and curettage (D&C) or evacuation (D&E) was used in the first and early second trimesters and induction was used later in pregnancy. The following were considered to be significant procedure-related complications: blood loss of more than 500 mL, uterine perforation, need for blood transfusion, allergic reaction, creation of a false passage (via falsa), systemic infection, readmission to hospital, any unplanned surgical procedure, such as repeat D&C/D&E or hysterectomy, and maternal death. The search of the hospital database identified 416 pregnancies that met the study criteria. Median maternal and gestational age at termination were 34.1 years and 17.4 weeks, respectively. In the first, second and third trimesters, respectively, 84 (20.2%), 278 (66.8%) and 54 (13.0%) pregnancies were terminated, for which D&C or D&E was used in 80 (95.2%), 21 (7.6%) and 0 (0.0%) cases. Seventy-seven (18.5%) women had at least one previous Cesarean section and 169 (40.6%) had at least one previous spontaneous delivery. Overall, 95 (22.8%) women had complications during or after TOP. A significantly higher complication rate was noted for terminations performed later in pregnancy. The median gestational age at termination was 16.6 weeks in women who did not experience complications and 20.7 weeks in those with complications (P < 0.001). The respective complication rates in the first, second and third trimesters were 6.0%, 27.0% and 27.8%. In women undergoing TOP for fetal defects, the risk of complications increases with advancing gestational age. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88-93Informations de copyright
© 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Références
Kagan KO, Sonek J, Kozlowski P. Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet 2022; 305: 825-835.
Kozlowski P, Burkhardt T, Gembruch U, Gonser M, Kähler C, Kagan KO, Kaisenberg C von, Klaritsch P, Merz E, Steiner H, Tercanli S, Vetter K, Schramm T. DEGUM, ÖGUM, SGUM and FMF Germany Recommendations for the Implementation of First-Trimester Screening, Detailed Ultrasound, Cell-Free DNA Screening and Diagnostic Procedures. Ultraschall Medizin 2019; 40: 176-193.
Kagan K, Tercanli S, Hoopmann M. Ten reasons why we should not abandon a detailed first trimester anomaly scan. Ultraschall Medizin 2021; 42: 451-459.
Salomon LJ, Alfirevic Z, Bilardo CM, Chalouhi GE, Ghi T, Kagan KO, Lau TK, Papageorghiou AT, Raine-Fenning NJ, Stirnemann J, Suresh S, Tabor A, Timor-Tritsch IE, Toi A, Yeo G. ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2013; 41: 102-113.
Karim JN, Roberts NW, Salomon LJ, Papageorghiou AT. Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance. Ultrasound Obstet Gynecol 2017; 50: 429-441.
Karim JN, Bradburn E, Roberts N, Papageorghiou AT, Papageorghiou AT, Alfirevic Z, Chudleigh T, Goodman H, Ioannou C, Longworth H, Karim JN, Nicolaides KH, Pandya P, Smith G, Thilaganathan B, Thornton J, Rivero-Arias O, Campbell H, Juszczak E, Linsell L, Wilson E, Hinton L, Fisher J, Duff E, Rhodes A, Yaz G. First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2022; 59: 11-25.
Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, Atrash HK. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-737.
Bryant AG, Grimes DA, Garrett JM, Stuart GS. Second-trimester abortion for fetal anomalies or fetal death. Obstet Gynecol 2011; 117: 788-792.
Exception to liability for abortion (Section 218a, German Criminal Code), 1998, amended 2021. https://www.lewik.org/term/15722/exception-to-liability-for-abortion-section-218a-german-criminal-code/.
German/Austrian and Swiss Society of Obstetrics and Gynecology. [National guideline: Induction of labour]. https://www.awmf.org/uploads/tx_szleitlinien/015-088ladd_S2k_Geburtseinleitung_2021-04.pdf.
Costescu D, Mui C. When there is only one patient: Induction of labour for termination of pregnancy. Best Pract Res Clin Obstetrics Gynaecol 2021; 79: 81-94.
Soon JA, Costescu D, Guilbert E. Medications used in evidence-based regimens for medical abortion: an overview. J Obstetrics Gynaecol Can 2016; 38: 636-645.
Prodan N, Breisch J, Hoopmann M, Abele H, Wagner P, Kagan KO. Dosing interval between mifepristone and misoprostol in second and third trimester termination. Arch Gynecol Obstet 2019; 299: 675-679.
Wagner N, Abele H, Hoopmann M, Grischke EM, Blumenstock G, Wallwiener D, Kagan KO. Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivates. Eur J Obstet Gynecol Reprod Biol 2011; 155: 75-78.
Diaz V, Abalos E, Carroli G. Methods for blood loss estimation after vaginal birth. Cochrane Database Syst Rev 2018; 2018: CD010980.
Prevention and management of postpartum haemorrhage: Green-top Guideline No. 52. BJOG 2017; 124: e106-149.
German, Austrian and Swiss Society of Obstetrics and Gynecology. [National guideline: Peripartal hemorrhage, diagnosis and therapy]. https://register.awmf.org/assets/guidelines/015-063l_S2k_Peripartale_Blutungen_Diagnostik_Therapie_PPH_2022-09_2.pdf.
Mark KS, Bragg B, Talaie T, Chawla K, Murphy L, Terplan M. Risk of complication during surgical abortion in obese women. Am J Obstet Gynecol 2018; 218: 238.e1-5.
Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: A review of the literature. Contraception 2004; 70: 183-190.
Rouse CE, Eckert LO, Muñoz FM, Stringer JSA, Kochhar S, Bartlett L, Sanicas M, Dudley DJ, Harper DM, Bittaye M, Meller L, Jehan F, Maltezou HC, Šubelj M, Bardaji A, Kachikis A, Beigi R, Gravett MG; Global Alignment of Immunization Safety in Pregnancy (GAIA) Postpartum Endometritis, Infection following Incomplete or Complete Abortion Work Group. Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine 2019; 37: 7585-7595.
White K, Carroll E, Grossman D. Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception 2015; 92: 422-438.
Cleland K, Creinin MD, Nucatola D, Nshom M, Trussell J. Significant adverse events and outcomes after medical abortion. Obstet Gynecol 2013; 121: 166.
Say L, Brahmi D, Kulier R, Campana A, Gülmezoglu AM. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev 2002; 2010: CD003037.
Lederle L, Steinauer JE, Montgomery A, Aksel S, Drey EA, Kerns JL. Obesity as a risk factor for complications after second-trimester abortion by dilation and evacuation. Obstet Gynecol 2015; 126: 585-592.
EUROCAT Prevalence Charts and Tables. https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en.
Bardi F, Bakker M, Kenkhuis MJA, Ranchor AV, Bakker MK, Elvan A, Birnie E, Bilardo CM. Psychological outcomes, knowledge and preferences of pregnant women on first-trimester screening for fetal structural abnormalities: A prospective cohort study. PLoS One 2021; 16: e0245938.
Davies V, Gledhill J, McFadyen A, Whitlow B, Economides D. Psychological outcome in women undergoing termination of pregnancy for ultrasound-detected fetal anomaly in the first and second trimesters: a pilot study. Ultrasound Obstet Gynecol 2005; 25: 389-392.